Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.
ACS Chemical Neuroscience August 1, 2026 DOI: 10.1021/acschemneuro.6c00138 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | Argues that β-arrestin2 signaling is a critical mediator of psychedelic drug effects, potentially explaining their therapeutic benefits and guiding drug development. |
Abstract
Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.
Citations in the library
Cites 35
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
- Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo Neuron July 5, 2021
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels Neuropsychopharmacology January 26, 2019
- 5-HT2AReceptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex Journal of Neuroscience April 15, 1997
and 30 more in the library